Three years ago there was not a single antidiabetic drug that U.S. doctors could prescribe generally, and of two under test, one (carbutamide) was dropped for fear of liver damage. Diabetes victims were slaves to insulin and the needle. Last week 515 experts gathered in Manhattan under the auspices of the New York Academy of Sciences for the second symposium in seven months on the several drugs now being promoted: three on general prescription,* three being tested on patients under research safeguards.†
On some points the researchers purred harmoniously; on others they disagreed violently....
To continue reading:
or
Log-In
